In the Track Your Plaque program, we aim to stop or reduce your heart scan score.
Recall that, without any preventive efforts, heart scan scores can be expected to increase at the average rate of 30% per year (faster at lower scores, slower at higher scores by a quirk of arithmetic).
I am continually surprised at how often people--that is, people not in the Track Your Plaque program--are often content with what I term "deceleration," or the slowing of plaque growth. In truth, most people are content with deceleration of plaque growth because they simply don't know that plaque continues to grow.
For instance, the BELLES Trial ( Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) ), reported in 2005 showed that 650 women participants continued to increase heart scan scores 15% whether they took "high-intensity" statin therapy in the form of Lipitor 80 mg or "low-intensity" statin therapy as pravastatin 40 mg, even though the group taking Lipitor experienced twice the amount of LDL reduction. In other words, heart scan scores continued to increase at the same rate of 15% per year regardless of the intensity of LDL lowering by statin drug.
In other words, if we are content to sit back and take Lipitor or other statin drug, follow the conventional American Heart Association low-fat, low-cholesterol diet, we will experience somewhere between 15 to 27% annual plaque growth --year after year.
No wonder that conventional advice offered by your friendly neighborhood doctor will avoid (postpone?) only one heart attack in four.
Such is the nature of coronary plaque deceleration: growth is modestly slowed, but is not stopped. Nor is it reversed.